Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Phenethylamines and Serotonin

supplement:

Phenethylamines

Research Papers that Mention the Interaction

The finding that phenylethylamine and tryptamine are endogenous enhancers of the impulse propagation mediated release of catecholamines and serotonin in the brain, and the development of synthetic enhancer substances opened the possibility to stimulate catecholaminergic and serotonergic neurons in the brain stem via a previously unknown mechanism.
Progress in Neuro-Psychopharmacology and Biological Psychiatry  •  2006  |  View Paper
Methamphetamine and MDMA as well as similar substituted phenethylamines are toxic to DA and/or 5-HT neurons.
NIDA research monograph  •  1996  |  View Paper
Phenylethylamine administration influences other neurotransmitters such as dopamine, norepinephrine and 5-hydroxytryptamine.
Progress in Neuro-Psychopharmacology and Biological Psychiatry  •  1984  |  View Paper
Similarly, inhibition of PEA deamination occurred at a faster rate than that of 5-HT metabolism.
Biochemical pharmacology  •  1981  |  View Paper
The phenethylamine derivatives , 4-fluoroamphetamine, 2-methylamino-3,4-methylene-dioxy-propiophenone (methylone), 1-(1,3-benzodioxol-5-yl)-2-butanamine (BDB), and N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB), had strong inhibitory effects on the re-uptake of dopamine, 5-HT and norepinephrine.
European journal of pharmacology  •  2007  |  View Paper
The results suggest (1) that phenylethylamine may exert its behavioural effects through increased release of both DA and 5-HT , and (2) that in vivo measurements of the acid metabolites alone may not be indicative of the release of the amines.
Neurochemical Research  •  2004  |  View Paper
The increase in the release of serotonin in the dorsalis raphe nucleus caused by local application of parachlorophenylethylamine (10(-6) M) reduced striatal [3H]serotonin release.
Neuroscience  •  1990  |  View Paper
Kinetic studies in mitochondrial preparations from both tissues of the rat showed that with both 5-HT and PEA as substrates the inhibition was of the competitive type when the enzyme preparation and the inhibitor were not preincubated prior to assay.
European journal of pharmacology  •  1983  |  View Paper
However, the fact that phenethylamine derivatives activate the serotonin uptake mechanism but do not induce platelet shape change suggests that serotonin uptake and serotonin-induced shape change are mediated by two distinct activation sites of serotonin receptors.
Biochimica et biophysica acta  •  1982  |  View Paper
Abstract Administration of either indoleamine or phenylethylamine hallucinogens selectively increased the level of serotonin within cell bodies of both the dorsal and median raphe nuclei.
Life sciences  •  1980  |  View Paper
Show More